Self-regulation for Older Adults With Asthma Through Remote Education
SOAR
1 other identifier
interventional
20
1 country
3
Brief Summary
This research is studying whether changing an individual's behaviors may have an impact as a treatment or outcome for asthma. The purpose of this study is to implement and evaluate an asthma self-management intervention through multiple locations in the United States that is tailored to the challenges older adults face and is based on an individual behavioral theory of change. Eligible participants will be enrolled and participate for six weeks in the SOAR intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable asthma
Started Jun 2023
Shorter than P25 for not_applicable asthma
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedStudy Start
First participant enrolled
June 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedJuly 1, 2024
June 1, 2024
11 months
February 1, 2023
June 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The Feasibility of Intervention Measure (FIM) of the SOAR intervention for patients and providers
A 4-item instrument to assess perceived intervention feasibility. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean. Higher scores indicate greater perceived feasibility.
Day 43
Acceptability of Intervention Measure (AIM) of the SOAR intervention for patients and providers
A 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean. Higher scores indicate greater perceived acceptability.
Day 43
Intervention Appropriateness Measure (IAM) for patients and providers
This is a 4-item measure of perceived intervention appropriateness. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean. Higher scores indicate greater perceived appropriateness.
Day 43
Secondary Outcomes (6)
Change in Asthma control will be determined with the Asthma Control Test (ACT)
baseline to 6 months
Change in Perceived Control of Asthma Questionnaire (PCAQ)
baseline to 6 months
Change in Health Care Communication Questionnaire (HCCQ)
baseline to 6 months
Change in Geriatric Depression Scale - Short Form (GDS-SF-15)
baseline to 6 months
Change in Mini Asthma Quality of Life Questionnaire (AQOL)
baseline to 6 months
- +1 more secondary outcomes
Study Arms (1)
SOAR intervention
EXPERIMENTALThe SOAR intervention will be a remote intervention that will follow a self-regulation process in which the participant first selects a specific problem to address and researches how asthma is preventing resolution of the problem, and finally identifies and develops a plan to achieve the objective.
Interventions
This program intervention will be over 6 weeks and participants will have two group sessions and individual sessions, all conducted by an asthma health coach over Zoom (or phone). The two Zoom group sessions will be recorded so that all the information from the conversations will be maintained and used for research purposes. Additionally, participants will keep track of asthma symptoms and complete surveys at specified time-points (the last one at 6 months after participation). Primary care physicians will be sent emails regarding the self-management goals of their patients.
Eligibility Criteria
You may qualify if:
- Physician diagnosis of asthma
- Poorly controlled asthma, as evidenced by a score ≤ 19 on the Asthma Control Test
- Have a primary care provider willing to participate in the study by receiving email updates regarding the status of the participant
You may not qualify if:
- Physician diagnosis of any other significant cardiopulmonary disease (including chronic obstructive pulmonary disease)
- A greater than 20 pack-year smoking history
- Lack of telephone access
- Decreased cognitive capacity such that participation in the program would not be possible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- American Lung Associationcollaborator
Study Sites (3)
University of Illinois-Chicago
Chicago, Illinois, 60607, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
University of Vermont
Burlington, Vermont, 05405, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alan Baptist, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Internal Medicine
Study Record Dates
First Submitted
February 1, 2023
First Posted
February 10, 2023
Study Start
June 13, 2023
Primary Completion
May 14, 2024
Study Completion
May 31, 2024
Last Updated
July 1, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share